跳至主要内容
临床试验/IRCT138807022499N1
IRCT138807022499N1已完成未知

Sequential therapy versus the best quadriple drug therapy for helicobacter pylori eradication

Vice Chancellor For Research, Mazandaran University of Medical Sciences0 个研究点目标入组 296 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
296

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
All

入选标准

  • age more than 18 years
  • Exclusion criteria: Previous history of receiving any H.p eradication regimen, Taking H2 blocker, proton pump inhibitor, Bismuth or Antibiotics during the 2 weeks prior to the study, Taking anticoagulants, ketoconazole or corticosteroids, History of gastric or esophageal surgery, Severe cardiovascular, pulmonary or endocrine disease, Renal failure, Hepatic diseases, Malignancies, Alcoholism, G6PD deficiency, Pregnancy or breast feeding

排除标准

  • 未提供

研究者

发起方
Vice Chancellor For Research, Mazandaran University of Medical Sciences

相似试验